Bio-Thera(SH:688177) Shang Hai Zheng Quan Bao·2025-05-05 19:13Meeting Overview - The annual general meeting of Baotai Biopharmaceutical Co., Ltd. was held on April 30, 2025, with no resolutions being rejected [2][4] - The meeting was convened by the board of directors and chaired by Chairman Li Shengfeng, complying with relevant laws and regulations [2][3] Attendance - Out of 8 current directors, 7 attended the meeting, while all 3 supervisors and the board secretary were present [3] - All senior management personnel attended the meeting [3] Resolutions Passed - The following resolutions were approved: 1. 2024 Annual Report and Summary [4] 2. 2024 Board of Directors Work Report [4] 3. 2024 Supervisory Board Work Report [5] 4. 2024 Financial Settlement Report [5] 5. 2024 Profit Distribution Plan [5] 6. 2025 Salary Plan for Directors and Senior Management [5] 7. Changes and Amount Adjustments for Certain Fundraising Projects [5] 8. Reappointment of Accounting Firm for 2025 [5] 9. Application for Comprehensive Credit from Financial Institutions [5] 10. Amendments to the Articles of Association and Corporate Governance [6] Board Election - The third board of directors was elected, consisting of 5 non-independent directors and 3 independent directors, with a term of three years starting from the approval date [10][11] - Li Shengfeng was elected as the chairman of the third board of directors [12] Management Appointments - The following senior management appointments were made: - Li Shengfeng as General Manager - Huang Xianming as Deputy General Manager - Yu Dan as Board Secretary - Zhan Xianhong as Chief Financial Officer [15] Legal Compliance - The meeting and voting procedures were verified by Shanghai Fangda (Guangzhou) Law Firm, confirming compliance with relevant laws and regulations [8]